Clinical Trials Insight: 700015677
Phase of Trial: Phase II
Latest Information Update: 11 Jun 2008
At a glance
- Drugs MTR 104 (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Meditor Pharmaceuticals
- 11 Jun 2008 Status changed from in progress to completed based on information from a Meditor Pharmaceuticals media release.
- 11 Jun 2008 Results have been reported in a Meditor Pharmaceuticals media release, and will be presented at an international conference for migraine in Europe.
- 06 Oct 2006 New trial record.